Cellectar Biosciences Inc (CLRB)
0.2496
-0.01
(-4.00%)
USD |
NASDAQ |
Dec 16, 14:15
Cellectar Biosciences Price to Book Value: 6.648 for Dec. 16, 2024
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Ionis Pharmaceuticals Inc | 9.207 |
| Ligand Pharmaceuticals Inc | 2.764 |
| Revance Therapeutics Inc | -- |
| Zymeworks Inc | 2.594 |
| Applied Therapeutics Inc | 22.02 |
Price to Book Value Related Metrics
| Price | 0.2496 |
| Earnings Yield | -761.2% |
| Market Cap | 10.30M |